Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against ESBL-producing Escherichia coli in 24-h time-kill experiments.
International Journal of Antimicrobial Agents(2019)
摘要
•Clinical efficacy of mecillinam is uncertain against ESBL-producing Escherichia coli.•Combination of mecillinam, amoxicillin and clavulanic acid has synergistic activity.•The three-drug combination could be clinically useful for urinary tract infections.
更多查看译文
关键词
Amdinocillin,Mecillinam,Synergy,Extended-spectrum β-lactamase,ESBL,Urinary tract infection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要